A hydrogen sulphide-releasing derivative of latanoprost acid (ACS 67) was synthesized and tested in vivo to evaluate its activity on reduction of intraocular pressure and tolerability. Glutathione (GSH) and cGMP content were also measured in the aqueous humour. The increased reduction of intraocular pressure, with a marked increase of GSH and cGMP and the related potential neuroprotective properties, make this compound interesting for the treatment of glaucoma.
Only registered users have access to the most valuable content of the FitEyes community: Blogs, Comments, FitEyes Discussion Group Archives, unique information on self-tonometry and other user-generated research.
You must register because we have content that cannot be viewed unless you agree to our terms and conditions.